In conclusion, ARHGEF17 plays an important role in tumor growth and dissemination, which together with the reduced survival of lung cancer patients with advanced disease and high ARHGEF17 expression, are consistent with a pathological role of ARHGEF17 in metastatic cancer. Here, ARHGEF17 is linked to lung carcinoma.